124.08
Finanzdaten der Jazz Pharmaceuticals Plc-Aktie (JAZZ)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
16.47%
1,045.71
|
897.84 | 1,088.17 | 1,054.97 | 1,023.83 |
|
81.61%
1,732.10
|
953.73 | 897.40 | 794.76 | 824.38 |
Benefits Costs and Expenses |
76.77%
1,781.27
|
1,007.65 | 954.95 | 854.16 | 885.90 |
Costs And Expenses |
81.61%
1,732.10
|
953.73 | 897.40 | 794.76 | 824.38 |
Operating Income/Loss |
1,128%
-686.39
|
-55.89 | 190.77 | 260.21 | 199.44 |
Income/Loss Before Equity Method Investments |
569.84%
-735.55
|
-109.81 | 133.22 | 200.81 | 137.93 |
Income/Loss From Equity Method Investments |
84.13%
-0.086
|
-0.542 | -0.016 | -0.285 | -0.012 |
Income/Loss From Continuing Operations Before Tax |
569.84%
-735.55
|
-109.81 | 133.22 | 200.81 | 137.93 |
Income Tax Expense/Benefit, Deferred |
51.53%
-66.42
|
-43.83 | -2.355 | -64.40 | -75.18 |
Income Tax Expense/Benefit |
3.60%
-17.17
|
-17.81 | -57.91 | -14.53 | -30.65 |
Income/Loss From Continuing Operations After Tax |
676.29%
-718.38
|
-92.54 | 191.13 | 215.34 | 168.57 |
|
676.38%
-718.47
|
-92.54 | 191.12 | 215.06 | 168.57 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.35%
61.19
|
60.98 | -0.437 | 61.41 | 62.88 |
Diluted Average Shares |
0.35%
61.19
|
60.98 | -1.504 | 63.17 | 69.62 |
Basic Earnings Per Share |
672.37%
-11.74
|
-1.52 | 3.13 | 3.50 | 2.68 |
Diluted Earnings Per Share |
672.37%
-11.74
|
-1.52 | 3.02 | 3.42 | 2.49 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):